What does CUSIP 28658R106 represent in this 13F holders report?

CUSIP 28658R106 is the security identifier for CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

How many institutions held CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share in Q1 2026?

2 institutional investors reported CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share for Q1 2026. Use the holders table for investor-level position and value details.

Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM)

CUSIP: 28658R106

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 68,580,003
Total 13F shares: 665
Share change: -52,820
Total reported value: $4,555
Price per share: $6.85
Number of holders: 2
Value change: -$211,265
Number of buys: 1
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 28658R106?
CUSIP 28658R106 identifies CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 28658R106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	16%	11,293,828	$77,711,233	—	31 Dec 2025	13F
AI ETI LLC	3/4/5	10%+ Owner	— class O/S missing	5,009,400	$62,617,500	—	12 Aug 2021	3/4/5
MPM BioImpact LLC	13D/G 13F	Company	5.6%	2,671,480	$13,437,544	$0	31 Dec 2025	13D/G 13F
Pontifax Management 4 G.P. (2015) Ltd.	13D/G	Pontifax VI G.P. L.P.	7.7%	5,206,380	$12,911,822	$0	27 Jun 2024	13D/G
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.8%	1,923,639	$7,695,000	—	31 Dec 2025	13F
ADAR1 Capital Management, LLC	13F	Company	2.1%	1,432,475	$5,729,900	—	31 Dec 2025	13F
VANGUARD GROUP INC	13F	Company	2%	1,340,504	$5,362,016	—	31 Dec 2025	13F
Affinity Asset Advisors, LLC	13F	Company	1.9%	1,300,000	$5,200,000	—	31 Dec 2025	13F
Kynam Capital Management, LP	13F	Company	1.5%	1,028,341	$4,113,364	—	31 Dec 2025	13F
GREAT POINT PARTNERS LLC	13F	Company	1.4%	979,534	$3,918,136	—	31 Dec 2025	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	1.4%	932,247	$3,728,988	—	31 Dec 2025	13F
Point72 Asset Management, L.P.	13F	Company	1%	716,680	$2,866,720	—	31 Dec 2025	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.88%	600,946	$2,403,784	—	31 Dec 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.83%	566,712	$2,266,848	—	31 Dec 2025	13F
Peapod Lane Capital LLC	13F	Company	0.83%	565,992	$2,263,968	—	31 Dec 2025	13F
Aoife Brennan	3/4/5	President and CEO, Director	— mixed-class rows	954,382 mixed-class rows	$2,042,709	-$25,154	06 Jan 2026	3/4/5
NAN FUNG TRINITY (HK) Ltd	13F	Company	0.68%	463,654	$1,854,616	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.65%	445,342	$1,781,368	—	31 Dec 2025	13F
Kevin Kotler	13F	Individual	0.58%	400,000	$1,600,000	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	0.57%	389,309	$1,557,236	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.47%	320,600	$1,282,400	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.45%	310,756	$1,243,615	—	31 Dec 2025	13F
MARSHALL WACE, LLP	13F	Company	0.44%	304,015	$1,216,060	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.43%	296,314	$1,185,256	—	31 Dec 2025	13F
Stephen Basil Thomas	3/4/5	Director	— mixed-class rows	194,657 mixed-class rows	$1,116,399	-$879,382	25 Feb 2026	3/4/5
TD ASSET MANAGEMENT INC	13F	Company	0.36%	246,200	$984,800	—	31 Dec 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.35%	239,043	$956,172	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.33%	224,883	$899,532	—	31 Dec 2025	13F
683 Capital Management, LLC	13F	Company	0.29%	201,652	$806,608	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.27%	187,403	$749,612	—	31 Dec 2025	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.23%	159,300	$637,200	—	31 Dec 2025	13F
Brett Kaplan	3/4/5	Chief Operating Officer	— mixed-class rows	577,500 mixed-class rows	$618,450	—	13 Jan 2025	3/4/5
MORGAN STANLEY	13F	Company	0.22%	148,538	$594,152	—	31 Dec 2025	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.21%	140,617	$566,650	—	31 Dec 2025	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.2%	139,529	$558,116	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.19%	128,900	$515,600	—	31 Dec 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.18%	124,700	$498,800	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.18%	124,670	$498,680	—	31 Dec 2025	13F
ArchPoint Investors	13F	Company	0.18%	121,400	$485,600	—	31 Dec 2025	13F
Squadron Capital Management LLC	13F	Company	0.15%	100,000	$400,000	—	31 Dec 2025	13F
OMERS ADMINISTRATION Corp	13F	Company	0.12%	85,466	$341,864	—	31 Dec 2025	13F
Seven Fleet Capital Management LP	13F	Company	0.11%	76,400	$305,600	—	31 Dec 2025	13F
UBS Group AG	13F	Company	0.1%	71,323	$285,292	—	31 Dec 2025	13F
Valerie Morisset	3/4/5	EVP, R&D AND CSO	— mixed-class rows	41,515 mixed-class rows	$249,910	—	19 Jul 2024	3/4/5
LPL Financial LLC	13F	Company	0.09%	62,000	$248,000	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.09%	61,853	$247,412	—	31 Dec 2025	13F
Hudson Bay Capital Management LP	13F	Company	0.07%	48,736	$194,944	—	31 Dec 2025	13F
XTX Topco Ltd	13F	Company	0.05%	34,852	$139,408	—	31 Dec 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.05%	34,596	$138,384	—	31 Dec 2025	13F
CITIZENS FINANCIAL GROUP INC/RI	13F	Company	0.04%	28,168	$112,672	—	31 Dec 2025	13F

Institutional Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q1 2026

As of 31 Mar 2026, Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 665 shares. The largest 2 holders included NISA INVESTMENT ADVISORS, LLC and Fortitude Family Office, LLC. This page lists 2 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

-62

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.